Glyburide |
Diabeta; Glynase; Micronase |
Glibenclamide Systematic (IUPAC) name 5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl) phenyl]ethyl]-2-methoxy-benzamide Identifiers CAS number 10238-21-8 ATC code A10BB01 PubChem 3488 DrugBank APRD00233 Chemical data Formula C23H28N3ClO5S Mol. weight 494.004 g/mol Pharmacokinetic data Bioavailability ? Protein binding Extensive Metabolism Hepatic hydroxylation (CYP2C9-mediated) Half life 10 hours Excretion Renal and biliary Therapeutic con ...
Wikipedia - [full article]
Glyburide Clinical Trials
- Glyburide Compared to Insulin in the Management of White''s Classification A2 Gestational Diabetes
ClinicalTrials.gov Identifier: NCT00160485 - Recruiting
Gestational Diabetes
- AVANDIA With Glyburide In African American And Hispanic Patients With Type 2 Diabetes Not Controlled by Glyburide Alone
ClinicalTrials.gov Identifier: NCT00333723 - Completed
Non-Insulin-Dependent Diabetes Mellitus
- A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00035568 - Completed
Diabetes Mellitus, Non-Insulin-Dependent
- A Research Study to determine the safety and efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents with Type 2 Diabetes.
ClinicalTrials.gov Identifier: NCT00035542 - Completed
Diabetes Mellitus, Non-Insulin-Dependent
- Vascular Effects of Rosiglitazone Vs. Glyburide
ClinicalTrials.gov Identifier: NCT00123643 - Completed
Type 2 Diabetes
- Effect of GlucoNorm vs Glyburide on Post-Prandial Hyperglycemia in Elderly Subjects With Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00451620 - Recruiting
Type 2 Diabetes
- Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide
ClinicalTrials.gov Identifier: NCT00279045 - Completed
Non-Insulin-Dependent Diabetes Mellitus
- A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes.
ClinicalTrials.gov Identifier: NCT00388986 - Completed
Diabetes Mellitus, Type 2
- Type 2 Diabetes Patients Switched From Sulfonylurea With Metformin to Glyburide/Metformin Combination Tablet
ClinicalTrials.gov Identifier: NCT00541437 - Completed
Type 2 Diabetes Mellitus
- Determine whether glycemic control is different between Lantus & a 3rd oral agent when failure with other treatment
ClinicalTrials.gov Identifier: NCT00046462 - Completed
Diabetes Mellitus
- A Comparison of Pioglitazone HCl and Glyburide in the Treatment of Patients With Type 2 Diabetes Mellitus and Mild Cardiac Disease
ClinicalTrials.gov Identifier: NCT00521742 - Completed
Diabetes Mellitus, Type 2; Cardiac Disease
- A Study to Compare Pioglitazone HCl and Glyburide for the Treatment of Subjects With Type 2 Diabetes Mellitus and Mild to Moderate Congestive Heart Failure
ClinicalTrials.gov Identifier: NCT00521820 - Completed
Type 2 Diabetes Mellitus; Congestive Heart Failure

Not Signed In -


